We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-8.74%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.03B
AUM Growth
-$97.2M
Cap. Flow
+$5.15M
Cap. Flow %
0.5%
Top 10 Hldgs %
54.98%
Holding
5,775
New
1,132
Increased
1,485
Reduced
1,487
Closed
1,545

Top Buys

Rank Stock Value
1
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$37.1M
2
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$19M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$17.1M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$13M
5
XLU icon
State Street Utilities Select Sector SPDR ETF
XLU
+$12.8M

Top Sells

Rank Stock Value
1
SMH icon
VanEck Semiconductor ETF
SMH
+$34M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$21.4M
3
VNQ icon
Vanguard Real Estate ETF
VNQ
+$18.6M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$16.8M
5
TZA icon
Direxion Daily Small Cap Bear 3x ETF
TZA
+$11.1M

Sector Composition

Rank Sector Weight
1 Financials 2.17%
2 Healthcare 1.69%
3 Industrials 1.67%
4 Technology 1.59%
5 Consumer Discretionary 1.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FPO
1851
DELISTED
First Potomac Realty Trust
FPO
$18K ﹤0.01%
+1,641
New +$18K
FRP
1852
DELISTED
Fairpoint Communications, Inc.
FRP
$18K ﹤0.01%
+1,148
New +$19.4K
SPAN
1853
DELISTED
Span-America Medical Systems I
SPAN
$18K ﹤0.01%
1,042
+149
+17% +$2.67K
EPRS
1854
DELISTED
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
$18K ﹤0.01%
+4,121
New +$24.2K
AHRT
1855
AH Realty Trust
AHRT
$517M
$17K ﹤0.01%
1,700
-7,162
-81% -$71.9K
ALGN icon
1856
Align Technology
ALGN
$12.3B
$17K ﹤0.01%
291
-203
-41% -$12.1K
AMGN icon
1857
Amgen
AMGN
$222B
$17K ﹤0.01%
124
-676
-85% -$107K
ASRT
1858
DELISTED
Assertio
ASRT
$17K ﹤0.01%
15
-52
-78% -$88.8K
ATEX icon
1859
Anterix
ATEX
$1.94B
$17K ﹤0.01%
571
-2,197
-79% -$71.9K
BBC icon
1860
Virtus Biotech Clinical Trials ETF
BBC
$49.9M
$17K ﹤0.01%
650
+646
+16,150% +$21.9K
CANE icon
1861
Teucrium Sugar Fund
CANE
$61M
$17K ﹤0.01%
+1,973
New +$16.9K
CATX icon
1862
Perspective Therapeutics
CATX
$342M
$17K ﹤0.01%
1,236
+262
+27% +$3.78K
CCJ icon
1863
Cameco
CCJ
$42.4B
$17K ﹤0.01%
+1,400
New +$18.9K
CMCSA icon
1864
Comcast
CMCSA
$90B
$17K ﹤0.01%
588
-3,364
-85% -$99.9K
CSR
1865
Centerspace
CSR
$952M
$17K ﹤0.01%
219
-856
-80% -$61.2K
CTRN icon
1866
Citi Trends
CTRN
$605M
$17K ﹤0.01%
731
+667
+1,042% +$16.4K
DXCM icon
1867
DexCom
DXCM
$32B
$17K ﹤0.01%
796
-3,684
-82% -$82.2K
FEMS icon
1868
First Trust Emerging Markets Small Cap AlphaDEX Fund
FEMS
$251M
$17K ﹤0.01%
+649
New +$19.1K
FLO icon
1869
Flowers Foods
FLO
$1.57B
$17K ﹤0.01%
683
-118
-15% -$2.68K
FNDF icon
1870
Schwab Fundamental International Large Company Index ETF
FNDF
$25.5B
$17K ﹤0.01%
+732
New +$18.8K
GBDC icon
1871
Golub Capital BDC
GBDC
$3.42B
$17K ﹤0.01%
1,099
-3,488
-76% -$56.4K
HBIO icon
1872
Harvard Bioscience
HBIO
$29.2M
$17K ﹤0.01%
+456
New +$21.2K
HY icon
1873
Hyster-Yale Materials Handling
HY
$665M
$17K ﹤0.01%
300
-1,536
-84% -$98K
IGR
1874
CBRE Global Real Estate Income Fund
IGR
$713M
$17K ﹤0.01%
2,251
+1,553
+222% +$12.1K
ILMN icon
1875
Illumina
ILMN
$28.4B
$17K ﹤0.01%
97
-2,215
-96% -$448K
73 74
75
76 77

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2015 Portfolio in Review

As of Q3 2015, Tower Research Capital (TRC) held 5,775 positions worth $1.03B, down 8.6% from $1.13B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Tower Research Capital (TRC)'s Q3 2015 filing shows 1,132 new, 1,485 increased, 1,487 reduced and 1,545 closed positions. Its largest new stake was iShares Russell 2000 ETF: 144,546 shares worth $15.8M. The largest sale was VanEck Semiconductor ETF, an estimated $34M.

By sector, the portfolio is most concentrated in Financials at 2.2% of assets, down from 2.5% a quarter earlier, followed by Healthcare and Industrials.

  • Tower Research Capital (TRC)'s largest Q3 2015 buy was iShares Russell 2000 ETF: 144,546 shares worth $15.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q3 2015, an estimated $37.1M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2015 reduction was VanEck Semiconductor ETF, cutting an estimated $34M.
  • Tower Research Capital (TRC) fully exited Vanguard Extended Market ETF in Q3 2015, selling an estimated $10M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 55% of its $1.03B portfolio in Q3 2015.
  • Tower Research Capital (TRC) opened 1,132 new positions and closed 1,545 in Q3 2015.
  • Tower Research Capital (TRC)'s portfolio value fell 8.6% quarter-over-quarter to $1.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2015, filed 13 Nov 2015.